课题基金 / 基金详情

ポジトロン断層法によるヒト脳ドーパミン代謝測定へのF-18標識プロドラッグの応用

ポジトロン断層法によるヒト脳ドーパミン代謝測定へのF-18標識プロドラッグの応用
F-18标记前药在正电子断层扫描人脑多巴胺代谢测量中的应用
批准号:
04670714
负责人:
ISHIWATA Kichi
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在体内评价了氟化多巴前药作为PET研究突触前多巴胺代谢的示踪剂的潜力。6-[^<18>F]氟- o- pivalyl - l- dopa (6-[^<18>F]FPDOPA)是由4- o- pivalyl - l- dopa与乙酰[^<18>F]次萤石直接氟化制备的。小鼠对该化合物的脑摄取低于6-[^<18>F]FDOPA;然而,6-[^<18>F]fdopa中纹状体对其他参考区域的吸收比大于6-[^<18>F]fdopa。芳香氨基酸脱羧酶和儿茶酚- o -甲基转移酶抑制剂增强纹状体的选择性摄取;6-[^<18>F]FDOPA的效果小于6-[^<18>F]FDOPA。l -苯丙氨酸负载降低了这两种化合物的脑摄取,这表明化合物通过血脑屏障的运输是由中性氨基酸转运系统介导的。HPLC分析发现纹状体中存在6-[^<18>F]FPDOPA、6-[^<18>F]FDOPA、6-[^<18>F]氟多巴胺等代谢物,但其他脑区未发现6-[^<18>F]氟多巴胺。结果表明,6-[^<18>F]FPDOPA具有作为多巴前药的潜力。6-[^<18>F]FDOPA经盐酸水解后,用缓冲生理盐水作为洗脱液进行高效液相色谱分离,得到无菌无孕6-[^<18>F]FDOPA注射液。与以前报道的方法相比,该方法适用于人体PET研究的常规生产。在使用6-[^<18>F]FDOPA的人体PET研究中,通过PET获得的大脑代谢图像与MRI获得的结构图像精确地叠加,已经发展起来。在正常受试者中进行了纹状体域胺代谢的半定量评估。
英文摘要
The potential of a fluorinated dopa prodrug as a tracer for studying presynaptic dopamine metabolism by PET was evaluaed in vivo. 6-[^<18>F]fluoro-O-pivaloyl-L-dopa (6-[^<18>F]FPDOPA) was prepared by direct fluorination of 4-O-pIVALOYl-L-dopa with acetyl [^<18>F]hypofluorite. In mice, brain uptake of the compound was lower than that of 6-[^<18>F]FDOPA ; however, the uptake ratios of striatum-to-other reference regions was larger in the 6-[^<18>F]FPDOPA than in the 6-[^<18>F]fdopa. Inhibitors of aromatic amino acid decarboxylase and catechol-O-methyl transferase enhanced selective uptake by the striatum ; the effect was smaller for 6-[^<18>F]FPDOPA than for 6-[^<18>F]FDOPA.reduced brain uptake of both compounds by L-phenylalanine-loading suggested that transport of the compounds across the blood-brain barrier was mediated by the neutral amino acid transoport system. BY HPLC analysis, 6-[^<18>F]FPDOPA, 6-[^<18>F]FDOPA, 6-[^<18>F]fluorodopamine and other metabolies were found in the striatum, although 6-[^<18>F]fluorodopamine was not found in other brain regions. The results show the potential of 6-[^<18>F]FPDOPA as a dopa prodrug.The HCl-hydrysis of 6-[^<18>F]FPDOPA followed by HPLC separation using the buffered physiological saline as an eluting solution, gave a steril and apyrogenic 6-[^<18>F]FDOPA injection. The method was suitable for routine production in human PET studies as compared to the methods reported prevously. In human PET studies using 6-[^<18>F]FDOPA, the metabolic images of the brain obtained by PET were superimposed precicely to the structual images obatined by MRI, has been developed. Semi-quantitative assesment of doamine metabolism in the striatum has been performed in normal subjects.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
K.Ishiwata,S.Ishii,M.Senda,Y.Tsuchiya,K.Tomimoto: "Electrophilic synthisis of 6-〔^<18>F〕fluoro-L-dopa: use of 4-O-pivaloy-L-DOPA as a suitabic precursor for routine produdion." Appl.Radiat.Isot.44. 755-759 (1993)
K. Ishiwata、S. Ishii、M. Senda、Y. Tsuchiya、K. Tomimoto:“6-〔^<18>F〕氟-L-多巴的亲电合成:使用 4-O-pivaloy-L-DOPA作为常规生产的合适前体。”Appl.Radiat.Isot.44. 755-759 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Ishiwata,S.Ishii,M.Senda: "HPLC using physiological salinefor the quality control of nadiopharmaceutecels used in PETstudies." Appl.Radiat.Isot.44. 1119-1124 (1993)
K.Ishiwata、S.Ishii、M.Senda:“使用生理盐水的 HPLC 对 PET 研究中使用的 nadiopharmaceutecels 进行质量控制。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    海外基金